Humira (Adalimumab)

  • Brand Name: HUMIRA
  • Active Ingredient: Adalimumab
  • Dosage Form: Injection: 40 mg/0.5 mL in a single-use prefilled pen (HUMIRA Pen)
  • Injection: 40 mg/0.5 mL in a single-use prefilled glass syringe
  • Manufacturer Name: Abbott Pharma. (Abbvie)
Get Price
Category:

Description

Humira Uses

HUMIRA (adalimumab injection) is indicated for the treatment of :

Rheumatoid Arthritis (RA): Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA.

Juvenile Idiopathic Arthritis (JIA): Reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.

Psoriatic Arthritis (PsA): Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA.

Ankylosing Spondylitis (AS): Reducing signs and symptoms in adult patients with active AS.

Adult Crohn’s Disease (CD): Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.

Pediatric Crohn’s Disease: Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn’s disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.

Ulcerative Colitis (UC): Inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to immunosuppressants such as corticosteroids, azathioprine or 6-mercaptopurine (6-MP). The effectiveness of HUMIRA has not been established in patients who have lost response to or were intolerant to TNF blockers.

Dosage: Adalimumab is administered by subcutaneous injection. The recommended dose of Adalimumab for adult patients with rheumatoid arthritis, psoriatic arthritis, or Ankylosing spondylitis is 40 mg administered every other week. The recommended Adalimumab dose regimen for adult patients with Crohn’s disease is 160 mg initially at Day 1 (administered as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days), followed by 80 mg two weeks later (Day 15). Two weeks later (Day 29) began a maintenance dose of 40 mg every other week. The recommended dose of Adalimumab for adult patients with plaque psoriasis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.

Side Effects: The most commonly reported adalimumab side effects include:

  • Rash
  • Sinusitis
  • Cytopenia
  • Headache
  • Heart failure
  • Lupus-like syndrome
  • Upper respiratory infection
  • Injection site reaction

Warnings and Precautions:

  • Humira is not recommended in case of any active infection as it can cause severe infection.
  • During ongoing therapy of inj adalimumab 40 mg the patient is seen suffering from lymphoma causing fatalities.
  • During Humira therapy, serious hypersensitivity reactions may occur.
  • During or after the therapy there are chances of reactivation of the hepatitis B virus.
  • If the patient developed cytopenias or pancytopenia then the use of humira injection should be discontinued immediately.
  • If lupus-like syndrome occurs then the use of Humira should be stopped.

More Info.

Storage: Adalimumab must be refrigerated at 2°C to 8° C (36°F to 46° F). Do not freeze this medication. Protect the prefilled syringe from exposure to light. Store in the original carton until the time of administration.

Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the HUMIRA at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the HUMIRA.

Buying Procedure: In order to buy HUMIRA, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp +919650877511 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, standard Prescription and Medical Reports.

Conclusion: Humira FDA label is one of the best treatment prescribed for autoimmune disorders such as plaque arthritis. Along with the medication and treatment the patient is recommended to take appropriate measures such as yoga, walk, or meditation.

FAQ

What is HUMIRA?
Humira is a disease-modifying antirheumatic drug and monoclonal antibody that acts in order to inactivate tumor necrosis factor-alpha (TNFα).

How is HUMIRA supplied?
HUMIRA (Adalimumab) is supplied in prefilled syringes as a preservative-free, sterile solution for subcutaneous administration.

What is the best price for HUMIRA?
Please contact +91 8130290915 for the HUMIRA price in India. We take a guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

How can I get HUMIRA in India?
HUMIRA is a prescription-only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – info@theindianpharma.com

We facilitate by-

  • Helping in documentation to import the medicine for personal use

  • Finding Genuine and reliable source in USA, Europe and Japan

  • Ensuring 100% transparency.


HUMIRA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of HUMIRA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees.

Can I get HUMIRA even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country.

The Indian Pharma can facilitate the supply of HUMIRA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Send your inquiry to find HUMIRA (Adalimumab) in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

How do I contact The Indian Pharma?
You can use a different channel to contact The Indian Pharma (TIP) Tele & Mobile: You can reach us on +91 9650877511 or +91-120-4080562.
Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours along with humira cost & procurement details after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working day after receiving your query form.